These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 8872901
1. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. Karpus WJ, Kennedy KJ, Smith WS, Miller SD. J Neurosci Res; 1996 Aug 15; 45(4):410-23. PubMed ID: 8872901 [Abstract] [Full Text] [Related]
2. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. J Exp Med; 1995 Jul 01; 182(1):75-85. PubMed ID: 7540658 [Abstract] [Full Text] [Related]
3. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes. Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H. J Neurosci Res; 1996 Aug 15; 45(4):430-8. PubMed ID: 8872903 [Abstract] [Full Text] [Related]
4. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD. J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809 [Abstract] [Full Text] [Related]
5. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance. Kennedy KJ, Smith WS, Miller SD, Karpus WJ. J Immunol; 1997 Jul 15; 159(2):1036-44. PubMed ID: 9218627 [Abstract] [Full Text] [Related]
7. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H. J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788 [Abstract] [Full Text] [Related]
8. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA, Weiner HL. Proc Natl Acad Sci U S A; 1996 Jan 09; 93(1):388-91. PubMed ID: 8552644 [Abstract] [Full Text] [Related]
9. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. Yu M, Johnson JM, Tuohy VK. J Neurosci Res; 1996 Aug 15; 45(4):463-70. PubMed ID: 8872907 [Abstract] [Full Text] [Related]
10. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation. Katsara M, Deraos S, Tselios TV, Pietersz G, Matsoukas J, Apostolopoulos V. Immunotherapy; 2014 Aug 15; 6(6):709-24. PubMed ID: 25186603 [Abstract] [Full Text] [Related]
11. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. Zhang H, Podojil JR, Chang J, Luo X, Miller SD. J Immunol; 2010 Jun 15; 184(12):6629-36. PubMed ID: 20483764 [Abstract] [Full Text] [Related]
12. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. J Clin Invest; 1996 Jul 01; 98(1):70-7. PubMed ID: 8690806 [Abstract] [Full Text] [Related]
13. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. J Neuroimmunol; 1992 Jun 01; 38(3):229-40. PubMed ID: 1376328 [Abstract] [Full Text] [Related]
14. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL. Eur J Immunol; 1998 Sep 01; 28(9):2780-90. PubMed ID: 9754565 [Abstract] [Full Text] [Related]
15. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD. J Immunol; 1998 May 01; 160(9):4271-9. PubMed ID: 9574529 [Abstract] [Full Text] [Related]
16. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, Collins M. J Immunol; 2000 Apr 01; 164(7):3563-72. PubMed ID: 10725711 [Abstract] [Full Text] [Related]
17. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Kel J, Oldenampsen J, Luca M, Drijfhout JW, Koning F, Nagelkerken L. Am J Pathol; 2007 Jan 01; 170(1):272-80. PubMed ID: 17200200 [Abstract] [Full Text] [Related]